chitosan has been researched along with dolutegravir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzeziński, M; Fang, H; Luo, RH; Priya Dharshini, K; Ramya Devi, D; Vedha Hari, BN; Yang, JX; Zheng, YT | 1 |
| B Narayanan, VH; D, RD; K, PD; S, B | 1 |
2 other study(ies) available for chitosan and dolutegravir
| Article | Year |
|---|---|
pH-sensitive chitosan nanoparticles loaded with dolutegravir as milk and food admixture for paediatric anti-HIV therapy.
Topics: Administration, Oral; Animal Shells; Animals; Anti-HIV Agents; Biopolymers; Cell Line; Child; Chitosan; Crustacea; Drug Carriers; Drug Liberation; Food; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Milk; Nanoparticles; Oxazines; Particle Size; Piperazines; Pyridones; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spray Drying; Temperature | 2021 |
In-vivo pharmacokinetic studies of Dolutegravir loaded spray dried Chitosan nanoparticles as milk admixture for paediatrics infected with HIV.
Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Drug Carriers; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Mice; Milk; Nanoparticles; Oxazines; Piperazines; Pyridones | 2022 |